Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
New Study: Negotiated Hepatitis C Prescription Drug Costs in United States Often Lower than in Price-Controlled European Countries and Japan

A new report, "Comparison of Hepatitis C Treatment Costs," shows Hepatitis C drug prices, specifically negotiated by pharmacy benefit managers (PBMs) in Medicare Part D in 2015, were typically lower than prices in Europe and Japan.

Published
20 September 2016
From
Yahoo News
HCV treatment is effective and may work as prevention for people who inject drugs

Hepatitis C treatment for people who inject drugs is as safe and effective as it is for non-drug-users – with cure rates exceeding 90% – and treating

Published
20 September 2016
By
Liz Highleyman
Behind Battle Over Drug Prices, Quiet Money From Big Pharma

Is there a conflict of interest for hepatitis C advocates in accepting funds from pharmaceutical companies and representing the interests of patients when questions of drug pricing and access to treatment are being debated?

Published
19 September 2016
From
Bloomberg
NHS funding cuts ‘forcing people to buy medicine through Facebook’

Patients and researchers say the medicine is safe, however pharmacists have warned that medicine bought online could be placebo pills or contain dangerous ingredients.

Published
16 September 2016
From
The Independent
Hepatitis C vaccine development shows progress but scientific barriers remain

An effective vaccine may be necessary to eliminate hepatitis C virus (HCV) but development has been hampered by several challenges including the variability of the virus and

Published
14 September 2016
By
Liz Highleyman
Inventor of Hepatitis C Cure Wins a Major Prize—and Turns to the Next Battle

Lasker Award winner Michael Sofia created a pill to fight an incurable virus. Now he is setting his sights on another.

Published
13 September 2016
From
Scientific American
ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced that it has taken a major step forward in its pursuit of a potentially curative combination therapy for chronic hepatitis B (HBV).

Published
12 September 2016
From
ContraVir press release
Ethiopia unable to provide effective national response to viral hepatitis

Ethiopia still lacks required partnerships and resource mobilization for an effective national health response to viral hepatitis, according to a report published in BMC Public Health.

Published
12 September 2016
From
Healio
UK: More options to be made available to treat hepatitis C

New draft guidance published today from NICE recommends elbasvir-grazoprevir - one of the newer hepatitis C antiviral drugs that can offer patients more effective treatment.

Published
12 September 2016
From
NICE press release
Effective antiviral treatment reduces fatigue in people with chronic hepatitis C

Fatigue – a common symptom among people living with hepatitis C virus (HCV) infection – is associated with liver inflammation and fibrosis, but antiviral therapy that leads

Published
12 September 2016
By
Liz Highleyman
← First12345...206Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close